Iron Regulatory Proteins and Pharmacological Iron Modulators: Therapeutic Implications: Iron Regulatory Proteins and Modulators

نویسندگان
doi
10.22037/tpps.v9i1.46862
چکیده

Iron homeostasis in the human body is precisely regulated, primarily through the action of proteins such as hepcidin, produced by the liver. Hepcidin plays a crucial role in controlling iron release by binding to ferroportin, the exporter of iron from cells into circulation. Under normal conditions, absorbed iron effectively binds to transferrin for transport to various tissues. However, individuals with blood disorders requiring frequent blood transfusions are susceptible to iron overload. This condition arises because the body’s mechanisms for iron excretion become overwhelmed, leading to chronic accumulation of excess iron. Additionally, dysregulation of iron-related proteins, such as ferritin and transferrin receptors, can further complicate this imbalance in iron homeostasis. This review focused on iron hemostasis and the pharmacological treatments available for managing iron overload, with a particular focus on Deferoxamine and Deferasirox. These medications aim to chelate excess iron, promoting its excretion and alleviating the detrimental effects associated with chronic iron accumulation. By understanding the pathways and proteins involved in iron regulation, as well as the available treatment options, better strategies can be developed to address the challenges faced by patients with iron overload due to frequent blood transfusions.

کلیدواژه‌ها